Jerry Griffin, VP of Sales and Marketing at BayMedica, InMed’s subsidiary, joins this live panel discussion “Transforming the CPG Landscape: Why Rare Cannabinoids Ingredients are the Next Big Thing” to talk about the growing cannabinoid industry and how CPG companies are creating valuable innovative products with rare cannabinoid ingredients.
The live panel discussion was held at the Benzinga Cannabis Capital Conference on September 28, 2023.
Highlights from the panel discussion:
1:30 What’s changed in the industry that has sparked the growing interest and adoption of rare cannabinoids into new CPG products?
3:30 How can rare cannabinoids offer affordable innovation for CPG products?
4:45 What should CPG companies look for in rare cannabinoid ingredients?
7:34 How can rare cannabinoids add value to CPG products?
9:00 How do the additional of rare cannabinoids impact margins?
9:25 How important is purity and consistency of rare cannabinoid ingredients for CPG products?
10:45 What is needed to continue the growth of the rare cannabinoid industry?
16:00 What the future of the rare cannabinoid industry?
Watch panel discussion on Benzinga’s YouTube Channel.
